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Quiescent and serum-stimulated cultures of Swiss mouse embryo fibroblasts (MEF) showed alterations in cell morphology 
including an enlargement in size upon treatment with 2% dimethyi sulfoxide (DMSO). Treatment of MEF and monkey 
kidney epithelial cells (MK2) with 2% DMSO at the early periods of serum-stimulated growth inhibited RNA, protein 
and DNA synthesis. DMSO treatment of cells at late stages of serum-stimulated growth (MEF after 1 hr and MK2 cells 
after 3 hr of stimulation) had little effect on DNA and protein synthesis although cell enlargement occurred in these 
cells. When the [3SSlmethioulne labelled proteins of the control and the DMSO treated cells were analysed by high resolu- 
tion polyaerylamide gel eleetrophoresis, no apparent difference was observed in the pattern of intracellular proteins of 
these cells. In contrast, the extracellular levels of two serum-induced secreted proteins of MEF (Mr 48000 and 26000) 
were dramatically reduced by DMSO treatment. The DMSO sensitive 48 kDa protein was found to be the major compo- 
nent of the extraceilular matrix, while the 26 kDa protein was not. The 48 kDa protein was identified as plasminogen 
activator inhibitor (PAl-l). Densitometrie quantitation showed a gradual accumulation of this protein in the matrix of 
serum-stimulated cells. The deposition of this protein in the matrix was inhibited by DMSO. Fiow-cytometric quantita- 
tion of indirect immunofluorescence indicated higher intracellular levels of the 48 kDa protein in fetal calf serum 
(FCS) + DMSO treated cells, suggesting that the low level of this protein in the medium of DMSO treated cells is pro- 
bably due to lack of transport of this protein from the cells into the medium. 
DMSO --- cell proliferation --- PAl-1 secretion --- morphological changes 
INTRODUCTION 
Treatment of cultured cells with dimethyl sulfoxide 
(DMSO) resulted in a variety of effects. DMSO is a po- 
tent inducer of cell differentiation [1] which affects cell 
morphology [2-5]. The growth of some solid tumors has 
been shown to be inhibited by DMSO [2]. The polar sol- 
vent has been shown to increase the adhesiveness of low 
metastatic clones of 3LL carcinoma [6]. These effects were 
accompanied by reduced tumorigenecity and reversal of 
the malignant phenotype of cells to normal phenotype 
[7-11]. DMSO treatment enchanced albumin production 
in transformed hepatocytes [9], and decreased the binding 
of EGF to its receptor [12]. The production of 
plasminogen activator in human carcinoma was inhibited 
by DMSO [5]. Addition of DMSO selectively enhanced 
the incorporation of [3H]thymidine into cultured 
Novikoff hepatoma cells [13] but retarded the growth of 
murine erythroleukemia cells and led to the differentia- 
tion process [14]. Rubin and Earp [15] have shown that 
*Correspondence and reprints. 
DMSO selectively stimulated phosphorylation f tyrosine 
residues of the rat liver EGF receptor. 
To further understand the mode of action of DMSO, 
we have studied its effect on cultured mouse embryo 
fibroblasts. We have specifically studied its effect during 
mitogenic stimulation of quiescent cells. The results 
presented here indicate that DMSO treatment changes the 
morphology of the cells and interferes with crucial events 
of mitogenic stimulation. The extracellular levels of two 
serum-induced proteins of M r 48000 and 26000 were af- 
fected by DMSO treatment. Under these conditions, the 
serum-induced DNA synthesis was also inhibited sug- 
gesting the possible involvement of the DMSO sensitive 
48 kDa and 26 kDa proteins in the transfer of a mitogenic 
signal. 
MATERIALS AND METHODS 
Primary cultures of Swiss mouse mbryo fibroblasts were main- 
talned in Eagle's n.dnimum essential medium (MEM, Flow Labs, 
UK) containing 10070 bovine serum (Sera Labs, UK) and 50pg/ml 
gentamycin. Cells from the fourth passage onwards (secondary 
cultures) were used for experiments. Subconfluent monolayers 
were synchronized at quiescence bymaintaining in 0.5°70 serum 
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containing medium for 72 hr. Cells were stimulated from 
quiescence by the addition of medium containing 20% fetal calf 
serum. Cells were treated with 2% DMSO unless otherwise men- 
tioned. 
Radiolabelling of intracellular and secreted proteins 
Quiescent and stimulated cultures, grown in the presence and 
absence of DMSO, were labelled with 25/~Ci of PSS]methionine 
(Amersham, specific activity 1390 Ci/Mmol) at 37°C in Hank's 
balanced salt solution for 30 min. The radioactivity was chased 
for 30 min by incubating the cells in serum-free medium. The 
secreted proteins present in the chase-medium were analysed as 
mentioned earlier [16]. Cells were scraped in phosphate buffered 
saline (PBS) and lysed in the electrophoresis ample buffer. All 
samples were electrophoresed in 5-18% polyacrylamide gradient 
gels containing sodium dodecyl sulfate (SDS). 
The extracellular matrix (ECM) proteins were isolated as 
described by Laiho et ai. [17]. Immunopreciptation wascarried 
out as described earlier [18]. 
Analysis of nucleic acids 
DNA synthesis was monitored by labelling the monolayers 
(25 cm') with 10 ~Ci of PH]thymidine for 30 min. At the end 
of labelfing, cells were scraped, suspended inPBS and an equal 
volume of 20%0 trichloroacetic a id was added. The precipitate 
was collected under vacuum suction and the radioactivity retained 
in the filter was quantitated in a Packard liquid scintillation 
counter. For monitoring RNA synthesis, 25 cm 2 monolayers were 
labelled with 10/~Ci of [3H]uridine for 30 min and the incor- 
porated radioactivity was determined as described above. 
Flow cytometry 
when the quiescent cells were stimulated with 20% FCS, 
the cells showed enlargement in size and had large promi- 
nent nuclei. Treatment of quiescent cells with serum and 
DMSO led to further enlargement i  size. The cytoplasmic 
to nuclear volume ratio was altered in DMSO treated cells 
as compared to the untreated cells. The DMSO treated 
cells appeared more flattened and extended lengthwise. 
The changes in cell sizes in quiescent, FCS and 
FCS+DMSO treated cells were confirmed by flow 
cytometry. The results presented inFigure 1 D and E show 
the cell size increase in the following order: quiescent cells 
<serum-stimulated cells<quiescent cells treated with 
DMSO < serum-stimulated cells treated with DMSO. The 
additive ffect of serum and DMSO in increasing the cell- 
size is explicit in these experiments (Fig. 1 E). 
Effect of DMSO on secreted proteins 
Quiescent cultures of mouse embryo fibroblasts were 
stimulated with medium containing 20% FCS and grown 
in the presence and absence of DMSO. After 6 hr of 
DMSO treatment, cells were pulse-labeled with 
[35S]methionine, Following 60 min chase incubation, the 
secreted proteins were collected and analysed by 
SDS-PAGE. The electrophoretic profile shows a drastic 
reduction in the level of two secreted proteins of M r 
48 000 and 26 000 in the medium of cells that were treated 
with FCS + DMSO (Fig. 2). These proteins were absent 
in the conditioned medium of quiescent cells but were pre- 
sent in the medium of serum-stimulated cells. N- 
chlorosuccinamide cl aved peptide mapping of the 48, 45, 
40, and the 26 kDa secreted proteins and actin did not 
show any relationship to each other (results not shown). 
Cell size was determined by flow cytometry using a fluorescence 
activated cell (FAC) scanner (Becton and Dickinson). Cells were 
trypsinised, washed with PBS and fixed in 75% ethanol for i -6 
hr. Aliquots containing 2 × 106 cells were used for cell-size 
analysis and 10000 cells were sized with forward and side scat- 
tering. 
Indirect immunofluorescence 
Cells were collected in cold PBS, pelleted, fixed by the addition 
of 3.7%0 formaldehyde in PBS and vortexed to avoid cell aggrega- 
tion. Fixed cells were permeabilised by 0. 1%0 Triton X-100 treat- 
ment for 10 min, pelleted and then treated with rabbit antibody 
to plasminogen activator inhibitor (PAl-l) for 30 rain at room 
temperature. Excess antibody was removed by extensive washing 
of the cells with PBS before suspending them in FITC conjugated 
goat anti-rabbit IgG. Excess conjugate was removed by washing 
thrice with PBS and the fluorescence was monitored in the FAC 
scanner by gated scatter analysis. The percentage of positive cells 
in each histogram was taken from the right side of the gate. 
RESULTS 
Effect of DMSO on cell morphology 
Photomicrographs of quiescent, serum-stimulated and 
DMSO treated mouse embryo fibroblasts are shown in 
Figure I. Quiescent cells had very small nuclei. However, 
Effect of DMSO on matrix proteins 
The extracellular matrix proteins of DMSO treated and 
untreated cells (both quiescent and serum-stimulated) were 
analysed by SDS-PAGE. The 48 kDa secreted protein was 
found to be the major component of the extracellular 
matrix while the 26 kDa secreted protein was a non-matrix 
protein (Fig. 3, lanes A-D) .  DMSO inhibited the deposi- 
tion of the 48 kVa protein in the ECM of both quiescent 
(lane B) and serum-stimulated (lane D) cells. Densitometric 
quantitation showed 82~/0 reduction in the level of the 48 
kDa protein in the matrix of quiescent cells treated with 
DMSO for 6 hr in comparision to its level in the matrix 
of untreated quiescent cells. A 24% reduction in the level 
of this protein in the matrix of FCS + DMSO treated cells 
(6 hr treatment) was observed in comparision to its level 
in cells treated with FCS alone. The 48 kDa protein was 
barely visible in the electrophoretic profile of the medium 
proteins of quiescent cells (Fig. 2E) while it is prominent 
in the matrix protein profile of these cells (Fig. 3A). 
The time course of deposition of the 48 kDa protein in 
the matrix was followed in serum-stimulated cells in the 
presence and absence of DMSO and the results are 
presented in Figure 4. Two hours after stimulation of 
quiescent cells with FCS, a 10% reduction in the deposi- 
tion of the 48 kDa protein in the matrix was observed in
the presence of DMSO; the deposition of this protein pro- 
gressively declined to 75% at the end of l0 hr of DMSO 
treatment of serum-stimulated cells. The reduced levels of 
the 48 kDa protein in the medium of the DMSO treated 
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FIGURE 1. -- Morphology and cell-size analysis of MEF treated with DMSO. Cells were synchronized at quiescence by growing them 
in medium containing 0.5% serum for 72 hr. Quiescent cells were stimulated togrow by the addition of medium containing 20% 
FCS and treated with 2% DMSO. After 6 hr of DMSO treatment, cells were stained with Giemsa nd photographed. A, quiescent 
cells; B, FCS stimulated cells; C, FCS (20%) + DMSO (2%) treated cells. The graphs depict flow cytometric analysis of cell-size of 
the quiescent (D) and FCS stimulated (E) cells. In D and E, the dotted lines represent the cell-size distribution of the DMSO treated 
cells. In each case 10000 ceils were analysed. 
cells may be due to inhibition of transport of this protein 
into the medium. TSis was indeed is the case since the in- 
tracellular level of this protein was more in serum- 
stimulated cells that were treated with DMSO than that 
was observed in cells treated with serum'alone (Table I). 
There was no significant difference in the PAI-I specific 
fluorescence of resting cells treated with DMSO and the 
untreated cells. 
Identity of the 48 kDa protein 
Since plasminogen activator inhibitor (M r 48000) was 
reported to be a major matrix component [17] and our 
studies howed the 48 kDa protein as the major matrix 
protein, antibodies to PALl were used to identify this pro- 
tein. Immunoprecipitation studies howed that the 48 kDa 
protein was precipitated by antibodies to plasminogen ac- 
tivator inhibitor (PALl) suggesting that the 48 kDa 
secreted protein is related to PAI (Fig. 3, lanes F and G). 
TABLE I. -- Quantitation of PAI-I by indirect im- 
munofluorescence. 
Cells 
FCS stimulated cells reacted 
with normal serum 
Quiescent cells reacted 
with PAI-I antibody 
FCS stimulated cells reacted 
with PAI-I antibody 
FCS + DMSO treated cells reacted 
with PAI-I antibody 
Percent 
fluorescence s 
14.5 
42.2 
27.2 
60.7 
SFluorescence was quantitated by flow cytometry as described 
in Materials and Methods. In indirect immunofluorescenc 
measurements, normal rabbit serum treated cells were used as 
control to determine non-specific and background fluorescence. 
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FIGURE 2. - Effect of DMSO on intracellular and secreted proteins. Quiescent and serum-stimulated MEF were obtained as describ- 
ed in Materials and Methods. Monolayers (25 cm 2) of MEF were labelled with pSS]methionine for 30 min. After a 30-min chase, 
the cells and media were collected and the proteins were electrophoresed in 5-18070 polyacrylamide gradient gels containing SDS and 
the resolved proteins were fluorographed. Lanes A-D show the profiles of intracellular proteins: A, proteins of quiescent cells; B, 
proteins of quiescent cells treated with DMSO; C, proteins of serum-stimulated c lls; D, proteins of FCS-DMSO treated cells. Lanes 
E-G depict he profiles of secreted proteins: E, secreted proteins of quiescent cells; F, secreted protein of serum-stimulated cells; 
G, secreted proteins of FCS-DMSO treated cells. 
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FIGURE 3. - Identification of 48 kDa protein as PAI-I. Quies- 
cent cells were stimulated with 20070 FCS and labelled with 50 
/~Ci of PSS]methionine for30 rain in serum-free medium. The 
matrix proteins were isolated and immunoprecipitations were per- 
formed as described [17, 18]. A, matrix proteins of quiescent 
cells. B, matrix proteins of quiescent cells treated with DMSO. 
C, matrix proteins of serum-stimulated c lls. D, matrix proteins 
of serum-stimulated cells treated with DMSO. E, conditioned 
medium proteins of serum-stimulated cells F, conditioned 
medium proteins of serum-stimulated c lls immunoprecipitated 
with PAI-I antibody. G, matrix proteins from serum-stimulated 
cells immunoprecipitated with PAI-I antibody. 
The identity of the 26 kDa DMSO sensitive non-matrix 
protein was not established in this study. 
Effect of DM$O on intraceilular proteins 
Under the conditions of inhibition of the extracellular 
levels of the 48 kDa and the 26 kDa proteins, DMSO did 
not preferentially inhibit the synthesis of any intracellular 
protein in quiescent or stimulated cells (Fig. 2 A-D), 
though the total protein synthesis was inhibited substan- 
tially (Fig. 8). It is difficult to monitor the level of the 48 
kDa intracellular protein corresponding tothe DMSO in- 
hibited 48 kDa secreted protein from PAGE patterns since 
this was a minor band flanked closely by other protein 
bands. Therefore, indirect immunofluorescence based flow 
cytometric quantitation was carried out using antibodies 
to PAI-I. The results (Table I) indicate higher intracellular 
levels of thi~ protein in FCS + DMSO treated cells than 
those observed in cells stimulated with FCS alone. These 
experiments in combination with the observations of 
reduced amounts of the 48 kDa protein in the matrix of 
DMSO treated cells imply that the polar solvent interferes 
with the transport of this protein into the medium. 
Effect of DMSO on DNA synthesis 
Addition of medium containing 20°/0 FCS to quiescent 
mouse embryo fibroblasts, induced DNA synthesis and 
the synthesis reached a peak at 16-18 hr after the addi- 
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FIGURE 4.  - Kinetics of inhibition of the matrix-associated 48 
kDa protein levels by DMSO. Quiescent cells were labelled with 
pSS]methionine at different periods after treating with FCS (o) 
or FCS + DMSO (o). The proteins were analysed by SDS PAGE 
and fluorographed. The levels of the matrix-associated 48 kDa 
protein were quantitated bycomputer assisted densitometric scan- 
ning and the relative areas under the 48 kDa protein were used 
for the graph. 
tion of the medium (Fig. 5). At this point, 80070 inhibi- 
tion of DNA synthesis was observed in the FCS + DMSO 
treated cells. Further, there was a 6-hr delay before 
reaching the peak of DNA synthesis in FCS + DMSO 
treated cells. Addition of DMSO to epithelial cells (MK2) 
also resulted in the inhibition of DNA synthesis, though 
at reduced levels. Quiescent MK2 cells that were treated 
with medium containing 20°70 FCS + DMSO synthesised 
DNA only by 50070 of that observed in cells treated with 
FCS alone. 
In the studies described here, cells were treated with 2070 
DMSO; this concentration i hibited DNA synthesis by 
90070 (Fig. 6). Higher concentrations of DMSO (5-10070) 
resulted in complete abolition of serum-stimulated DNA 
synthesis. Cells treated with FCS + 5-10070 DMSO did not 
show any increase in DNA synthesis over the background 
levels observed in quiescent cells. However, these high cor~- 
centrations of the solvent were avoided due to possible 
deleterious effects on the cells. Serum.stimulated cells 
treated with 2070 DMSO for 6 hr were found to be com- 
pletely viable upon removal of DMSO and subsequent 
growth in serum-containing medium. Therefore, in all the 
studies described here, this concentration (2070) of DMSO 
was used. 
Addition of DMSO during the early periods of serum- 
stimulated growth had marked effects on DNA synthesis 
in MEF (Fig. 7A) and MK2 (Fig. 711) cells. Presence of 
DMSO up to 30-60 min of serum stimulation had drastic 
inhibitory effect on DNA synthesis n MEF and MK2 cells. 
DMSO added to cells at later stages of serum-stimulated 
growth showed little effect on DNA synthesis (Fig. 7A and 
7B) although cell enlargement was evident (results not 
shown). 
When [3H]thymidine uptake was monitored, it was 
found that treatment of FCS stimulated cells with 2070 
DMSO resulted in 40-45070 inhibition of thymidine incor- 
poration into the cells. The DMSO-mediated inhibition 
of DNA synthesis described above cannot be correlated 
solely with the inhibition of thymidine uptake since (a) 
the DNA synthesis was inhibited to a higher extent hat 
thymidine uptake and (b) the DNA synthesis was not 
inhibited significantly when the cells were treated with 
DMSO at the later stages (3 hr) of mitogenic stimuli 
(Fig. 7 A). 
Effect of DMSO on protein synthesis 
Incorporation of [3SS]methionine into total proteins of 
serum-stimulated cells that were treated with DMSO is 
shown in Figure 8. Incorporation of labelled methionine 
into intracellular and secreted proteins was affected when 
DMSO was added to the cells at early stages of serum- 
stimulated growth. Treatment of cells with DMSO upto 
30 min after serum stimulation had a more severe in- 
hibitory effect on total protein synthesis than when DMSO 
was added at later stages of serum stimulation. 
Effect of DMSO on RATA synthesis 
Since the synthesis of early RNAs was among the crucial 
events of cell proliferation [19-21]. RNA synthesis was 
monitored in both DMSO treated and untreated quiescent 
cells stimulated to grow by the addition of 20% FCS. The 
results indicate that RNA synthesis during the early period 
of mitogenic response was inhibited by 85070 (Fig. 9). Since 
the RNA synthesis was monitored in cells that were pulse- 
labelled for 30 min with PH]uridine, the inhibition may 
reflect a reduction in the synthesis of mRNAs. Although 
it is known that during the first few hours of serum 
stimulated growth, RNAs responsible for cell-cycle pro- 
gression are synthesised [19], the specificity of inhibition 
by DMSO of particular species of mRNAs is to be 
determined. 
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FIGURE 5. -- Effect of DMSO on DNA synthesis. Quiescent 
cultures of MEF or MK2 cells were pulse-labelled for30 min with 
[3H]thymidine atdifferent intervals after addition of 2007o FCS 
or 20°/0 FCS plus 2°70 DMSO. Cells were scraped and collected 
in PBS and the trichloroacetic a id precipitable counts were deter- 
mined, o, FCS stimulated MEF; e, FCS + DMSO treated MEF; 
[] FCS stimulated MK2 cells; =, FCS+ DMSO treated MK2 
cells. 
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is increased by plasminogen activator (PA) which converts 
the proenzyme plasminogen to the active form plasmin 
[27]. Matrix deposition of PAI could have important 
biological consequences resulting in the inhibition of pro- 
teolysis. Presence of PAI on the cell membrane may in- 
hibit the plasminogen activator activity thus preventing 
the pericellular proteolysis. Transfer of PAI from the 
membrane and deposition in the matrix may relieve the 
inhibition by PAI of the activity of the membrane 
associated PA; this might enable the activation of mem- 
brane bound plasminogen and trigger mitogenic stimuli 
by proteolytic cleavage (activation) of growth factors and 
(or) their receptors. 
FIGURE 6. -- Effect of DMSO concentration DNA synthesis 
in serum-stimulated MEF. Quiescent cultures were stimulated 
with different concentrations of DMSO. The quiescent (Q), 
serum-stimulated iCS) and DMSO treated cells were labelled 
for 30 min with 10/~Ci of [3H]thymidine. Trichloroacetic a id 
precipitable counts were determined The numbers below the bars 
indicate the percent of DMSO used. 
DISCUSSION 
Our studies on the effect of DMSO on mouse embryo 
fibroblasts how that it affects the morphology, inhibits 
the synthesis of RNA, DNA and proteins. The ex- 
tracellular levels of two proliferation-specific polypeptides 
of M, 48000 and 26000 were also affected by DMSO. 
The most dramatic inhibitory effects of DMSO were 
observed at the early phases of mitogenic stimuli, within 
30-45 min of serum-stimulated growth of mouse mbryo 
fibroblasts. 
The changes in the cell shape and DNA synthesis were 
shown to be related phenomena [22]. The enlargement of
cells in the G 1 phase of the cells was correlated with DNA 
synthesis in mammalian cells [23]. In transformed cells, 
DMSO treatment resulted in conferring non-malignant 
phenotype [2-4]. Our results on the morphological 
changes how increased spreading of cells upon DMSO 
treatment (Fig. I). DMSO-mediated cell enlargement was 
evident at all stages of serum-stimulated growth, while the 
polar solvent inhibited DNA synthesis only when it was 
added at the early stages of serum-stimulated growth. 
These results imply that the DMSO-mediated cell enlarge- 
ment and the inhibition of DNA synthesis were unrelated 
events in mouse embryo fibroblasts. 
Our previous tudies on secretory proteins howed that 
the 48 kDa and the 26 kDa proteins were proliferation- 
specific. These proteins were induced by mitogens and 
cycloheximide [24, 25]. The results presented here show 
that the 48 kDa protein is a serum-induced protein and 
is related to endothelial type plasminogen activator in- 
hibitor (Fig. 2). Addition of DMSO to quiescent and 
serum-stimulated cells reduced the level of the PAI-I 
related 48 kVa protein in the medium and interfered with 
its deposition in the extraceUular matrix. 
Cells in culture synthesise proteinases and their ac- 
tivators and inhibitors [26]. Plasminogen is one of the pro- 
teases ecreted by the cells. The activity of this enzyme 
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FIGURE 7. - Effect of DMSO on DNA synthesis n MEF (A) 
and MK2 (B) cells pretreated with 20% FCS. Quiescent cultures 
were stimulated togrow by the addition of 20% FCS. DMSO 
was added to cultures at different periods after serum stimula- 
tion. The numbers below the bars indicate the time (in rain) after 
serum stimulation and DMSO was added at these points. The 
DMSO treated and control dishes were labelled for 30 min with 
l0 ~Ci of [SH]thymidine at lg hr after serum stimulation. Cells 
were scraped and suspended in PBS and precipitated with equal 
volume of 10% trichloroacetic a id and the acid precipitable 
counts were determined. The letters Q and FCS below the bars 
indicate the extent of DNA synthesis inquiescent (Q) and serum- 
stimulated (FCS) cells that were not treated with DMSO. 
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FIGURE 8. - Effect of DMSO on protein synthesis in cells 
pretreated with 20% FCS. Quiescent cultures of MEF were 
stimulated togrow by the addition of 20% FCS. DMSO was add- 
ed to cultures at different periods after serum stimulation. FCS, 
serum-stimulated c lls. The numbers below the bars indicate the 
time (in min) of DMSO addition after serum stimulation. The 
DMSO-treated and control monolayers (25 cm 2) were labelled 
with 50/tCi of [3SS]methionine  5 ml of Hank's balanced salt 
solution for 30 min. After a 30-min chase incubation in the 
serum-free medium, the chase medium was collected and the cells 
were lysed with electrophoresis sample buffer. Aliquots of 
medium and cell lysates were precipitated with trichloroacetic 
acid and acid precipitable counts were determined. I-I, Condi- 
tioned medium proteins. I'I, Intracellular proteins. 
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FIGURE 9. -- Effect of DMSO on RNA synthesis. Quiescent 
cultures of mouse mbryo fibroblasts were labelled with l0/~Ci 
of PH]uridine for 30 min at different periods after addition of 
20% FCS or 20% FCS+DMSO. o, FCS stimulated cells; e, 
FCS + DMSO treated cells. 
Accumulation of PAI-I on the cell growth substratum 
has been reported by Pollanen eta/. [28]. PAl may be in- 
volved in the production of structural changes in cells apart 
from inhibiting the plasminngen activator. Quigley [27] 
showed changes in morphology in chick embryo 
fibroblasts transformed with Rous sarcoma virus as a 
result of enhanced PA activity. Addition of synthetic PAl 
inhibited these morphological changes. Lalho et al. [17] 
have reported the enhanced eposition of PAI-I on the 
ECM of human lung fibroblasts exposed to TGF ~. These 
studies indicate that ECM proteins play a major role in 
a number of phenomema such as tissue integrity, cell adhe- 
sion, metastasis and cell migration [29]. 
The primary effect of DMSO on cultured cells appears 
to be on the cell membrane and such an effect was shown 
to interfere with the binding of EGF with its receptor [12]. 
Alteration of membrane conformation may change the 
transport properties of the membrane. The higher in- 
tracellular levels of PAI-I in FCS + DMSO treated cells 
and lower levels in the medium of the same cells may 
reflect an impairment of transport of this protein from 
the cell to the medium as the result of DMSO mediated 
change of membrane structure. 
Synthesis of new mRNAs is required for the progres- 
sion of quiescent cells to enter through G1 [19]. Pardee 
eta/. [30] and Schneiderman eta/. [31] reported that pro- 
tein synthesis in the early G I phase of the cell cycle is 
directed by newly made mRNAs which are required for 
cell growth. Our results how that the early RNA synthesis 
is inhibited by DMSO treatment. The proto-oncogenes c- 
myc and c-fog are induced in quiescent cells at the early 
periods of addition of serum or growth factors [32, 33]. 
Apart from proto-oncogenes, several other cellular pro- 
teins were found, to be regulating the early GI phase 
[34-40]. Here we have shown the inhibition of the ex- 
tracellular levels of two early growth response proteins (the 
48 kDa and 26 kDa proteins) by DMSO. It is to be deter- 
mined whether DMSO affects the synthesis of mRNAs of 
these proteins and that of other early growth response 
genes including c-los and c-myc. 
Addition of serum or growth factors to quiescent cells 
induces several changes. An increase in the phospho- 
tidylinositol turnover, phosphorylation of proteins, 
autophosphorylation of growth factor receptors, increase 
in intracellular pH and Ca 2+, rearrangement of actin 
bundles, increase in nutrient transport and enhanced RNA 
synthesis are some of the consequences of serum- 
stimulated growth [34,41]. DMSO has been reported to 
stimulate tyrosine residue phosphorylation of epidermal 
growth factor (EGF) receptor and subsequently shown to 
affect he binding of EGF to its receptor [12]. The DMSO- 
mediated reduced binding of EGF to its receptor may 
result in the inhibition of DNA synthesis. It is to be deter- 
mined whether the DMSO sensitive 48 kDa and 26 kDa 
proteins influence any of the above growth-related vents. 
Since DMSO treatment of cells at late stages of mitogenic 
stimuli did not inhibit DNA synthesis and other early 
events, we presumed that the polar solvent may not have 
any effect when added after the early mitogenic signals 
were conveyed, and this was indeed what we have observ- 
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ed. We conclude that once the DMSO-sensitive arly 
mitogenic signals have been conveyed, DMSO treatment 
at later stages of mitogenic stimuli will be ineffective in 
inhibiting the signal(s). Dimethyl sulfoxide is often used 
in ointments and rubs as solvent and sometimes as home 
remedy for arthritis. Since treatment of cells with DMSO 
interferes with vital processes of growth as shown here, 
ce, ution must be exerted on its use in medical formulations. 
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